ARCHIVES

DCT Board Approves Drug Development Recompetition

This article is from The Cancer Letter archive.

Vol. 16 No. 46 | November 30, 1990

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group Clinical Trials Approved

January 29, 2010

Chemical, Viral Carcinogenesis Should Not Be Separated: Shimkin

July 14, 1978

CCOPs Favor Ability To Enter Patients On Any Group Study

June 12, 1998

House Reprogramming Of NCI Funds Analyzed; Community Programs Would Be Hurt

July 13, 1979

Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease

February 22, 2013

Program Announcement.

July 4, 2003